First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril
- 1 August 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (4), 239-245
- https://doi.org/10.1016/0002-9149(88)90219-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertensionThe American Journal of Cardiology, 1987
- Effect of ramipril on 24-hour variability of blood pressure and heart rate in essential hypertensionThe American Journal of Cardiology, 1987
- Measurement of plasma angiotensin IIClinical Science, 1985
- Can Placebo Therapy Influence Arterial Blood Pressure?Clinical Science, 1981
- Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captoprilAmerican Heart Journal, 1981
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- New system for recording ambulatory blood pressure in manMedical & Biological Engineering & Computing, 1978
- Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsBiochemistry, 1977
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- Estimation of Angiotensin II Concentration in Human Plasma by Radioimmunoassay. Some Applications to Physiological and Clinical StatesEuropean Journal of Clinical Investigation, 1971